Amicus Therapeutics Inc (FOLD)
10.54
-0.17
(-1.59%)
USD |
NASDAQ |
Apr 24, 16:00
10.52
-0.02
(-0.19%)
After-Hours: 20:00
Amicus Therapeutics Total Assets (Quarterly): 777.88M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 777.88M |
| September 30, 2023 | 764.08M |
| June 30, 2023 | 730.09M |
| March 31, 2023 | 700.52M |
| December 31, 2022 | 724.17M |
| September 30, 2022 | 759.53M |
| June 30, 2022 | 800.59M |
| March 31, 2022 | 826.94M |
| December 31, 2021 | 905.14M |
| September 30, 2021 | 956.68M |
| June 30, 2021 | 786.89M |
| March 31, 2021 | 810.03M |
| December 31, 2020 | 886.52M |
| September 30, 2020 | 900.54M |
| June 30, 2020 | 701.45M |
| March 31, 2020 | 738.35M |
| December 31, 2019 | 850.21M |
| September 30, 2019 | 882.29M |
| June 30, 2019 | 918.03M |
| March 31, 2019 | 764.70M |
| December 31, 2018 | 789.95M |
| September 30, 2018 | 838.59M |
| June 30, 2018 | 825.89M |
| March 31, 2018 | 870.00M |
| December 31, 2017 | 627.02M |
| Date | Value |
|---|---|
| September 30, 2017 | 680.78M |
| June 30, 2017 | 938.97M |
| March 31, 2017 | 993.38M |
| December 31, 2016 | 1.037B |
| September 30, 2016 | 918.18M |
| June 30, 2016 | 914.01M |
| March 31, 2016 | 862.91M |
| December 31, 2015 | 908.38M |
| September 30, 2015 | 986.69M |
| June 30, 2015 | 403.91M |
| March 31, 2015 | 192.62M |
| December 31, 2014 | 209.97M |
| September 30, 2014 | 125.49M |
| June 30, 2014 | 117.99M |
| March 31, 2014 | 112.36M |
| December 31, 2013 | 127.56M |
| September 30, 2013 | 69.11M |
| June 30, 2013 | 82.34M |
| March 31, 2013 | 93.22M |
| December 31, 2012 | 110.09M |
| September 30, 2012 | 118.21M |
| June 30, 2012 | 111.60M |
| March 31, 2012 | 120.80M |
| December 31, 2011 | 69.80M |
| September 30, 2011 | 78.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
700.52M
Minimum
Mar 2023
956.68M
Maximum
Sep 2021
811.58M
Average
800.59M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| TG Therapeutics Inc | 329.59M |
| Geron Corp | 394.08M |
| Vanda Pharmaceuticals Inc | 648.44M |
| Fate Therapeutics Inc | 506.22M |
| Editas Medicine Inc | 499.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 617.71M |
| Shareholders Equity (Quarterly) | 160.17M |
| Debt to Equity Ratio | 2.422 |
| Current Ratio | 2.881 |
| Net Debt Paydown Yield | 0.02% |